MICROZIDE Side Effects

7023432-4 | Blood Urine Present, Confusional State, Delirium, Depressed Level Of Consciousness, Diarrhoea, Hypoaesthesia, Hypokalaemia, Hyponatraemia, Oedema Peripheral
on Sep 20, 2010 Female patient from UNITED KINGDOM , 78 years of age, was diagnosed with hypertension, urinary tract infection (What is urinary tract infection?) and was treated with Microzide (View Usage). Patient experienced the following unwanted or unexpected effects: blood urine present, confusional state, delirium, depressed level of consciousness, diarrhoea, hypoaesthesia, hypokalaemia, hyponatraemia, oedema peripheral. Microzide dosage: Unk, For Many Years. During the same period patient was treated with NITROFURANTOIN (Unk) (View Nitrofurantoin Review and Nitrofurantoin Label ). Patient was hospitalized.

6922996-6 | Inappropriate Antidiuretic Hormone Secretion
Patient was taking Microzide (View Usage). Patient had the following side effects: inappropriate antidiuretic hormone secretion on Jul 30, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 76 years of age, was diagnosed with hypertension and. Microzide dosage: 50 Mg, Unk. During the same period patient was treated with RAMIPRIL (WATSON LABORATORIES) (5 Mg, Daily) (View Ramipril (watson Laboratories) Review and Ramipril (watson Laboratories) Label ). Patient was hospitalized.

6857496-5 | Inappropriate Antidiuretic Hormone Secretion
Adverse event was reported on Jul 07, 2010 by a Female patient taking Microzide (View Usage) (Dosage: 50 Mg, Unk) was diagnosed with hypertension and. Location: UNITED KINGDOM , 76 years of age, After Microzide was administered, patient had the following side effects: inappropriate antidiuretic hormone secretion. During the same period patient was treated with RAMIPRIL (WATSON LABORATORIES) (5 Mg, Daily) (View Ramipril (watson Laboratories) Review and Ramipril (watson Laboratories) Label ). Patient was hospitalized.

6697394-3 | Rhabdomyolysis
on Apr 12, 2010 Male patient from UNITED KINGDOM , 70 years of age, was diagnosed with on and off phenomenon, parkinson's disease (What is parkinson's disease?) and was treated with Microzide (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. Microzide dosage: Unk. During the same period patient was treated with QUETIAPINE (12.5 Mg, Unk) (View Quetiapine Review and Quetiapine Label ), RASAGILINE (Unk) (View Rasagiline Review and Rasagiline Label ), ROTIGOTINE (8 Mg Increased To 16 Mg) (View Rotigotine Review and Rotigotine Label ), LEVODOPA (400 Mg, Unk) (View Levodopa Review and Levodopa Label ). Patient was hospitalized.


6654269-3 |
on Mar 22, 2010 Female patient from UNITED STATES , 60 years of age, was treated with Microzide (View Usage). . Microzide dosage: . During the same period patient was treated with DILTIA XT (WATSON LABORATORIES) (View Diltia Xt (watson Laboratories) Review and Diltia Xt (watson Laboratories) Label ).

6643467-0 | Cross Sensitivity Reaction, Lichenoid Keratosis, Pruritus
Patient was taking Microzide (View Usage). After Microzide was administered, patient had the following side effects: cross sensitivity reaction, lichenoid keratosis, pruritus on Mar 08, 2010 from TUNISIA Additional patient health information: Male patient , 56 years of age, was diagnosed with hypertension and. Microzide dosage: Unk. During the same period patient was treated with FUROSEMIDE (WATSON LABORATORIES) (40 Mg, Daily) (View Furosemide (watson Laboratories) Review and Furosemide (watson Laboratories) Label ).

6633640-X | Dysarthria, Embolic Stroke, Hemianopia, Hypoaesthesia, Muscular Weakness
Adverse event was reported on Feb 22, 2010 by a Male patient taking Microzide (View Usage) (Dosage: Unk) was diagnosed with hypertension and. Location: UNITED KINGDOM , 77 years of age, Patient experienced the following unwanted or unexpected effects: dysarthria, embolic stroke, hemianopia, hypoaesthesia, muscular weakness. During the same period patient was treated with ENALAPRIL MALEATE (Unk) (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

6616228-6 | Dysarthria, Embolic Stroke, Hemianopia, Hypoaesthesia, Muscular Weakness
on Feb 22, 2010 Male patient from UNITED KINGDOM , 77 years of age, was diagnosed with hypertension and was treated with Microzide (View Usage). Patient had the following side effects: dysarthria, embolic stroke, hemianopia, hypoaesthesia, muscular weakness. Microzide dosage: Unk. During the same period patient was treated with ENALAPRIL MALEATE (WATSON LABORATORIES) (Unk) (View Enalapril Maleate (watson Laboratories) Review and Enalapril Maleate (watson Laboratories) Label ). Patient was hospitalized.

6410456-0 | Inappropriate Antidiuretic Hormone Secretion
on Oct 14, 2009 Male patient from SPAIN , 79 years of age, was diagnosed with hypertension, convulsion and was treated with Microzide (View Usage). After Microzide was administered, patient had the following side effects: inappropriate antidiuretic hormone secretion. Microzide dosage: . During the same period patient was treated with OXCARBAZEPINE (Unk) (View Oxcarbazepine Review and Oxcarbazepine Label ). Patient was hospitalized.

5841143-5 | Abdominal Pain, Blood Pressure Increased, Dizziness, Headache, Nausea
Patient was taking Microzide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood pressure increased, dizziness (What is dizziness?), headache (What is headache?), nausea (What is nausea?) on Aug 07, 2008 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 160.0 lb, was diagnosed with prehypertension and. Microzide dosage: 12.5 Once Daily Po.

5630823-2 |
Adverse event was reported on Feb 04, 2008 by a Female patient taking Microzide (View Usage) (Dosage: ) . Location: UNITED STATES , 65 years of age, . During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), CHLORDIAZEPOXIDE AND AMITRIPTYLINE (View Chlordiazepoxide And Amitriptyline Review and Chlordiazepoxide And Amitriptyline Label ), BUSPIRONE HCL (View Buspirone Hcl Review and Buspirone Hcl Label ), OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN (View Oxycodone Hydrochloride And Acetaminophen Review and Oxycodone Hydrochloride And Acetaminophen Label ), CALCIUM ANTAGONIST() (View Calcium Antagonist() Review and Calcium Antagonist() Label ), ANTIPSYCHOTIC, ATYPICAL() (View Antipsychotic, Atypical() Review and Antipsychotic, Atypical() Label ), COX 2 INHIBITOR() (View Cox-2 Inhibitor() Review and Cox-2 Inhibitor() Label ), ANTIHYPERLIPIDEMIC() (View Antihyperlipidemic() Review and Antihyperlipidemic() Label ).

5630452-0 |
on Feb 04, 2008 Male patient from UNITED STATES , 47 years of age, was treated with Microzide (View Usage). . Microzide dosage: . During the same period patient was treated with DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), CARDIAC GLYCOSIDES (View Cardiac Glycosides Review and Cardiac Glycosides Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ACE INHIBITOR NOS (View Ace Inhibitor Nos Review and Ace Inhibitor Nos Label ).